TrialJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2014

Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation.

Gerald V Naccarelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.